Portolan Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,600,902
| Closed | -$435K | – | 166 |
|
|
2022
Q3 | $435K | Sell |
1,600,902
-4,697
| -0.3% | -$1.28K | 0.05% | 126 |
|
|
2022
Q2 | $1.24M | Hold |
1,605,599
| – | – | 0.12% | 120 |
|
|
2022
Q1 | $1.72M | Buy |
1,605,599
+244,895
| +18% | +$262K | 0.14% | 121 |
|
|
2021
Q4 | $2.59M | Buy |
1,360,704
+97,283
| +8% | +$185K | 0.17% | 107 |
|
|
2021
Q3 | $3.8M | Sell |
1,263,421
-132,946
| -10% | -$400K | 0.28% | 100 |
|
|
2021
Q2 | $5.46M | Sell |
1,396,367
-124,538
| -8% | -$487K | 0.39% | 90 |
|
|
2021
Q1 | $7.71M | Buy |
1,520,905
+213,178
| +16% | +$1.08M | 0.61% | 68 |
|
|
2020
Q4 | $5.35M | Buy |
1,307,727
+6,652
| +0.5% | +$27.2K | 0.49% | 77 |
|
|
2020
Q3 | $6.32M | Buy |
1,301,075
+515,088
| +66% | +$2.5M | 0.72% | 58 |
|
|
2020
Q2 | $4.35M | Buy |
785,987
+310,191
| +65% | +$1.72M | 0.5% | 76 |
|
|
2020
Q1 | $1.56M | Buy |
+475,796
| New | +$1.56M | 0.23% | 101 |
|